Jiangsu Hengrui Medicine Co Ltd (600276) — Capital Reinvestment Ratio
Jiangsu Hengrui Medicine Co Ltd (600276) has a Capital Reinvestment Ratio of 0.09x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥4.81 Billion) in capital expenditures (CN¥446.90 Million). Check Jiangsu Hengrui Medicine Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jiangsu Hengrui Medicine Co Ltd Capital Reinvestment Ratio (1999–2024)
This chart tracks Jiangsu Hengrui Medicine Co Ltd's Capital Reinvestment Ratio across 26 annual periods. For the full cash flow conversion analysis, see Jiangsu Hengrui Medicine Co Ltd (600276) cash conversion ratio.
Annual Capital Reinvestment Ratio for Jiangsu Hengrui Medicine Co Ltd (1999–2024)
Year-by-year Capital Reinvestment Ratio for Jiangsu Hengrui Medicine Co Ltd from 1999 to 2024. See free cash flow generation of Jiangsu Hengrui Medicine Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.27x | CN¥7.42 Billion | CN¥1.97 Billion | ▲ +36.7% |
| 2023 | 0.19x | CN¥7.64 Billion | CN¥1.48 Billion | ▼ -87.7% |
| 2022 | 1.57x | CN¥1.27 Billion | CN¥1.99 Billion | ▲ +299.0% |
| 2021 | 0.39x | CN¥4.22 Billion | CN¥1.66 Billion | ▲ +144.3% |
| 2020 | 0.16x | CN¥3.43 Billion | CN¥554.33 Million | ▲ +9.8% |
| 2019 | 0.15x | CN¥3.82 Billion | CN¥561.35 Million | ▼ -22.9% |
| 2018 | 0.19x | CN¥2.77 Billion | CN¥529.11 Million | ▲ +27.8% |
| 2017 | 0.15x | CN¥2.55 Billion | CN¥380.30 Million | ▼ -65.2% |
| 2016 | 0.43x | CN¥2.59 Billion | CN¥1.11 Billion | ▲ +147.6% |
| 2015 | 0.17x | CN¥2.28 Billion | CN¥394.09 Million | ▼ -8.7% |
| 2014 | 0.19x | CN¥1.57 Billion | CN¥298.52 Million | ▼ -42.9% |
| 2013 | 0.33x | CN¥1.36 Billion | CN¥453.30 Million | ▼ -31.8% |
| 2012 | 0.49x | CN¥958.37 Million | CN¥466.83 Million | ▼ -52.5% |
| 2011 | 1.02x | CN¥527.36 Million | CN¥540.27 Million | ▲ +37.9% |
| 2010 | 0.74x | CN¥385.95 Million | CN¥286.73 Million | ▲ +130.3% |
| 2009 | 0.32x | CN¥439.12 Million | CN¥141.65 Million | ▼ -65.9% |
| 2008 | 0.95x | CN¥117.46 Million | CN¥111.21 Million | ▲ +210.0% |
| 2007 | 0.31x | CN¥218.87 Million | CN¥66.85 Million | ▼ -5.8% |
| 2006 | 0.32x | CN¥266.18 Million | CN¥86.29 Million | ▲ +17.1% |
| 2005 | 0.28x | CN¥227.88 Million | CN¥63.07 Million | ▼ -26.7% |
| 2004 | 0.38x | CN¥209.41 Million | CN¥79.11 Million | ▼ -76.1% |
| 2003 | 1.58x | CN¥136.82 Million | CN¥216.62 Million | ▼ -35.8% |
| 2002 | 2.47x | CN¥49.84 Million | CN¥122.90 Million | ▼ -89.7% |
| 2001 | 23.99x | CN¥11.49 Million | CN¥275.58 Million | ▲ +478.2% |
| 2000 | 4.15x | CN¥19.61 Million | CN¥81.34 Million | ▲ +591.8% |
| 1999 | 0.60x | CN¥33.89 Million | CN¥20.32 Million | — |